Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Payables (2016 - 2026)

Biomerica's Payables history spans 16 years, with the latest figure at $730000.0 for Q1 2026.

  • On a quarterly basis, Payables rose 15.51% to $730000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $730000.0, a 15.51% increase, with the full-year FY2025 number at $672000.0, up 20.0% from a year prior.
  • Payables hit $730000.0 in Q1 2026 for Biomerica, down from $740000.0 in the prior quarter.
  • Over the last five years, Payables for BMRA hit a ceiling of $2.6 million in Q1 2022 and a floor of $344000.0 in Q2 2023.
  • Historically, Payables has averaged $822728.4 across 5 years, with a median of $713000.0 in 2023.
  • Biggest five-year swings in Payables: soared 245.02% in 2022 and later crashed 85.16% in 2023.
  • Tracing BMRA's Payables over 5 years: stood at $670074.0 in 2022, then rose by 16.85% to $783000.0 in 2023, then increased by 8.3% to $848000.0 in 2024, then dropped by 12.74% to $740000.0 in 2025, then decreased by 1.35% to $730000.0 in 2026.
  • Business Quant data shows Payables for BMRA at $730000.0 in Q1 2026, $740000.0 in Q4 2025, and $681000.0 in Q3 2025.